Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases

Overview of attention for article published in Journal of Clinical Investigation, September 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 32 news outlets
blogs: 3 blogs
twitter: 78 X users
patent: 1 patent

facebook: 5 Facebook pages
reddit: 1 Redditor
f1000: 1 research highlight platform
video: 1 YouTube creator

Readers on

mendeley: 254 Mendeley

So far, Altmetric has seen 41 news stories from 32 outlets.

Could prostate drugs reduce Parkinson's disease risk?

Medical News Today, 06 Feb 2021

A new study suggests that repurposing glycolysis-enhancing drugs such as terazosin, which is typically used to treat an…

Un fármaco para la hiperplasia de próstata podría frenar el párkinson

Jano, 15 Oct 2019

PUBLICADO EN 'JOURNAL OF CLINICAL INVESTIGATION' JANO.ES · 15 octubre 2019 Un estudio del IDIBELL describe una nueva aplicación…

Kann ein altes Medikament die Parkinsonkrankheit bezwingen?

MSN, 04 Oct 2019

Gegen neurodegenerative Krankheiten wie Parkinson kann die Medizin noch wenig ausrichten.

Parkinson: Medicamento para a próstata pode ser aliado

Noticias ao Minuto PT, 02 Oct 2019

A terazosina, substância utilizada para o tratamento da próstata, pode ajudar a retardar a progressão da doença de Parkinson…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 37 additional news stories.